Cardiovascular disease is now the leading cause of adult death in the world. According to
new estimates from the World Health Organization, myocardial infarction (MI) is responsible …

Ischemic heart damage usually triggers cardiomyopathological remodeling and fibrosis, thus
promoting the development of heart functional failure. Mesenchymal stem cells (MSCs) are a …

Stem cell biology has informed and energized cardiac regenerative medicine. The field is
linked to a construct that challenges long-standing concepts and advances the basic tenets …

Permanent loss of cardiomyocytes and scar tissue formation after myocardial infarction (MI)
results in an irreversible damage to the cardiac function. Cardiac repair (replacement …

Although reperfusion therapy has improved outcomes, acute myocardial infarction (AMI) is
still associated with both significant mortality and morbidity. Once irreversible myocardial cell …

Cardiovascular disease constitutes the primary cause of mortality and morbidity worldwide,
and represents a group of disorders associated with the loss of cardiac function. Despite …

Mesenchymal stem cells have been used for cardiovascular regenerative therapy for
decades. These cells have been established as one of the potential therapeutic agents …

Lee and Walsh Future of Cardiovascular Regenerative Medicine 2619 cells by using
reprogramming factors. 16 This monumental achievement meant that potentially any cell …

It is estimated that by 2030, almost 23.6 million people will perish from cardiovascular
disease, according to the WHO. The review discusses advances in stem cell therapy for …

Cell therapy has the potential to improve healing of ischemic heart, repopulate injured
myocardium and restore cardiac function. The tremendous hope and potential of stem cell …